{"AllianceGenome": "7551", "HGNC": "7551", "MIM": "600958", "_id": "4607", "_version": 1, "accession": {"genomic": ["AC090582.9", "AY518390.1", "CH471064.2", "CP068267.2", "GU324918.1", "KU319882.1", "KU508441.1", "KU508442.1", "KU508443.1", "KU508444.1", "KU508445.1", "KU508446.1", "KU508447.1", "KU508448.1", "MF796226.1", "MH595891.1", "NC_000011.10", "NC_060935.1", "NG_007667.1", "U91629.1", "Y10129.1"], "protein": ["AAB35662.1", "AAB35663.1", "AAC04620.1", "AAI36544.1", "AAI36547.1", "AAI42686.1", "AAI51212.1", "AAR89909.1", "ABQ59032.1", "ACH92816.1", "ACH92817.1", "ADL14489.1", "ANI86415.1", "ANR02589.1", "ANR02590.1", "ANR02591.1", "ANR02592.1", "ANR02593.1", "ANR02594.1", "AXU41070.1", "BAF84258.1", "BAG60177.1", "CAA71216.1", "EAW67927.1", "EAW67928.1", "EAW67929.1", "NP_000247.2", "Q14896.4", "QBC17766.1"], "rna": ["AJ708511.1", "AJ708699.1", "AK291569.1", "AK297843.1", "AL691822.1", "AU140784.1", "BC136543.1", "BC136546.1", "BC142685.1", "BC151211.1", "DA563514.1", "EF560722.1", "EU747718.1", "EU747719.1", "NM_000256.3", "S80778.1", "S80782.1"], "translation": [{"protein": "BAF84258.1", "rna": "AK291569.1"}, {"protein": "AAI36547.1", "rna": "BC136546.1"}, {"protein": "ACH92816.1", "rna": "EU747718.1"}, {"protein": "ACH92817.1", "rna": "EU747719.1"}, {"protein": "BAG60177.1", "rna": "AK297843.1"}, {"protein": "AAI36544.1", "rna": "BC136543.1"}, {"protein": "ABQ59032.1", "rna": "EF560722.1"}, {"protein": "NP_000247.2", "rna": "NM_000256.3"}, {"protein": "AAI51212.1", "rna": "BC151211.1"}, {"protein": "AAB35663.1", "rna": "S80782.1"}, {"protein": "AAB35662.1", "rna": "S80778.1"}, {"protein": "AAI42686.1", "rna": "BC142685.1"}]}, "alias": ["CMD1MM", "CMH4", "FHC", "LVNC10", "MYBP-C", "cMyBP-C"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": [{"classification": "limited", "classification_date": "2020-09-04T16:00:00.000Z", "disease_label": "dilated cardiomyopathy", "gcep": "Dilated Cardiomyopathy Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0005021", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_652d0370-9574-450c-b7c4-eec86ade9046-2020-09-04T160000.000Z", "sop": "SOP7"}, {"classification": "limited", "classification_date": "2019-08-06T16:00:00.000Z", "disease_label": "arrhythmogenic right ventricular cardiomyopathy", "gcep": "Arrhythmogenic Right Ventricular Cardiomyopathy Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0016587", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0639d989-8415-425c-ab89-e8a3a0b6ea49-2019-08-06T160000.000Z", "sop": "SOP7"}, {"classification": "definitive", "classification_date": "2021-10-07T16:00:00.000Z", "disease_label": "hypertrophic cardiomyopathy", "gcep": "Hereditary Cardiovascular Disease Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0005045", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7e65896e-33f5-439d-8749-aba08a539dd0-2021-10-07T160000.000Z", "sop": "SOP8"}]}, "ensembl": {"gene": "ENSG00000134571", "protein": ["ENSP00000382193", "ENSP00000442795", "ENSP00000444259"], "transcript": ["ENST00000399249", "ENST00000544791", "ENST00000545968"], "translation": [{"protein": "ENSP00000382193", "rna": "ENST00000399249"}, {"protein": "ENSP00000442795", "rna": "ENST00000545968"}, {"protein": "ENSP00000444259", "rna": "ENST00000544791"}], "type_of_gene": "protein_coding"}, "entrezgene": "4607", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 40.0947704344, "exp_mis": 475.790294303, "exp_syn": 223.40398234, "lof_z": 3.61292900935812, "mis_z": 0.690434681255666, "mu_lof": 3.34439808955e-06, "mu_mis": 5.21688486308e-05, "mu_syn": 2.40251999355e-05, "n_lof": 17.0, "n_mis": 445.0, "n_syn": 264.0, "p_li": 1.35053975034244e-06, "p_null": 9.17167801485317e-05, "p_rec": 0.999906932680101, "syn_z": -1.68378731628978}, "bp": 3825, "cds_end": 47374198, "cds_start": 47353421, "n_exons": 34, "nonpsych": {"exp_lof": 35.7598102995, "exp_mis": 430.106315477, "exp_syn": 201.672351137, "lof_z": 3.24516692241385, "mis_z": 0.58627894214151, "mu_lof": 3.34439808955e-06, "mu_mis": 5.21688486308e-05, "mu_syn": 2.40251999355e-05, "n_lof": 16.0, "n_mis": 406.0, "n_syn": 238.0, "p_li": 1.58988961212072e-06, "p_null": 0.000436942665818004, "p_rec": 0.99956146744457, "syn_z": -1.6105602615386}, "nontcga": {"exp_lof": 36.8355457393, "exp_mis": 437.675458036, "exp_syn": 205.480043578, "lof_z": 3.7115818529233, "mis_z": 0.587623267295493, "mu_lof": 3.34439808955e-06, "mu_mis": 5.21688486308e-05, "mu_syn": 2.40251999355e-05, "n_lof": 14.0, "n_mis": 413.0, "n_syn": 239.0, "p_li": 5.8531693875155e-05, "p_null": 4.93176539100353e-05, "p_rec": 0.999892150652215, "syn_z": -1.48061285413657}, "transcript": "ENST00000545968.1"}, "exons": [{"cdsend": 47352647, "cdsstart": 47331870, "chr": "11", "position": [[47331405, 47331716], [47331844, 47331881], [47332071, 47332258], [47332565, 47332702], [47332813, 47332973], [47333193, 47333333], [47333556, 47333752], [47333921, 47334010], [47335041, 47335209], [47335876, 47336011], [47337390, 47337579], [47337689, 47337794], [47338519, 47338679], [47339323, 47339404], [47339650, 47339790], [47341002, 47341032], [47341137, 47341244], [47341990, 47342156], [47342577, 47342744], [47342829, 47342935], [47343020, 47343148], [47343491, 47343624], [47346206, 47346370], [47346626, 47346644], [47347421, 47347423], [47347424, 47347479], [47347650, 47347680], [47347856, 47347905], [47348423, 47348541], [47349773, 47349922], [47350013, 47350112], [47350501, 47350615], [47351238, 47351505], [47352622, 47352702]], "strand": -1, "transcript": "NM_000256", "txend": 47352702, "txstart": 47331405}], "exons_hg19": [{"cdsend": 47374198, "cdsstart": 47353421, "chr": "11", "position": [[47352956, 47353267], [47353395, 47353432], [47353622, 47353809], [47354116, 47354253], [47354364, 47354524], [47354744, 47354884], [47355107, 47355303], [47355472, 47355561], [47356592, 47356760], [47357427, 47357562], [47358941, 47359130], [47359240, 47359345], [47360070, 47360230], [47360874, 47360955], [47361201, 47361341], [47362553, 47362583], [47362688, 47362795], [47363541, 47363707], [47364128, 47364295], [47364380, 47364486], [47364571, 47364699], [47365042, 47365175], [47367757, 47367921], [47368177, 47368195], [47368972, 47368974], [47368975, 47369030], [47369201, 47369231], [47369407, 47369456], [47369974, 47370092], [47371324, 47371473], [47371564, 47371663], [47372052, 47372166], [47372789, 47373056], [47374173, 47374253]], "strand": -1, "transcript": "NM_000256", "txend": 47374253, "txstart": 47352956}], "generif": [{"pubmed": 11955864, "text": "Left ventricular hypertrophy can be a late manifestation of hypertrophic cardiomyopathy due to cardiac myosin-binding protein C mutations."}, {"pubmed": 12110947, "text": "Results suggest that the cardiac myosin-binding protein C gene (MYBPC3) is the predominant gene for hypertrophic cardiomyopathy in eastern Finland."}, {"pubmed": 14563344, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 15000344, "text": "Haplotype analysis suggested that the two most common variants (MYBPC3-Gln1061X and TPM1-Asp175Asn) were founder mutations."}, {"pubmed": 15213454, "text": "NMR assignment of domain C1 of the N-terminal myosin-binding site of human cardiac myosin binding protein C"}, {"pubmed": 15519027, "text": "MYBPC3-HCM virtually mimicked the phenotype of those with mutations in the beta-myosin heavy chain. Patients with multiple mutations had the most severe phenotype."}, {"pubmed": 15519027, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15563892, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15671604, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 15737656, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15737656, "text": "Our results point out that GG genotype of MYBPC3 might be a genetic risk factor for the expression of cardiac hypertrophic phenotype in the patients with hypertrophic cardiomyopathy."}, {"pubmed": 15769446, "text": "Truncated cMyBP-C resulting from human MYBPC3 mutations are rapidly and quantitatively degraded by the ubiquitin-proteasome system, which in turn may competitively inhibit breakdown of other proteasome substrates."}, {"pubmed": 16004897, "text": "role of MYBPC3 mutations in hypertrophic cardiomyopathy; three new mutations in three families (V771M, V342D, and A627V)were found; findings suggest a dosage effect for mutations at the MYPBC3 gene"}, {"pubmed": 16087648, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 16199542, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16566405, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 16651346, "text": "mutation in the TNNT2 gene with aggravating mutation in the MYBPC3 gene causing restrictive cardiomyopathy in a child"}, {"pubmed": 16754800, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17192269, "text": "lution structure of one part of the N-terminal binding site, the third immunoglobulin domain of the cardiac isoform of human MyBP-C (cC2) together with a model of its interaction with myosin"}, {"pubmed": 17560599, "text": "The compromised contractile function of the failing heart might be in part attributable to reduced cMyBP-C phosphorylation levels."}, {"pubmed": 17937428, "text": "identified a novel homozygous mutation, c.3330 + 2T > G, in the splice-donor site of MYBPC3 intron 30, resulting in skipping of the 140-bp exon 30, which led to a frame shift and premature stop codon in exon 31; phenotype found in Amish communities"}, {"pubmed": 18273486, "text": "Screening of the exons in hypertrophic cardiomyopathy revealed two variations - one novel frame shift mutation in exon 19 at the nucleotide position 11577-11578 and one novel single nucleotide polymorphism (SNP) in codon 1093 of exon 31."}, {"pubmed": 18337725, "text": "Four mutations in the MYBPC3 gene are found to be associated with hypertrophic cardiomyopathy; all four result in premature termination codons, which suggests that haploinsufficiency is a pathogenic mechanism of this type of mutation."}, {"pubmed": 18337725, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18374358, "text": "The structure of the immunoglobulin-like C1 domain of MyBP-C was solved by X-ray crystallography to a resolution of 1.55 A."}, {"pubmed": 18383048, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18403758, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18467358, "text": "Homozygous mutations in the MYBPC3 gene have been identified as the cause of severe infantile HCM among the Amish population."}, {"pubmed": 18513529, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18560154, "text": "Diffraction data from the C1 domain of cMyBP-C were extended to 1.30 A resolution, where the of the diffraction data crosses 2.0, using intense synchrotron radiation."}, {"pubmed": 18573260, "text": "MyBP-C is a highly phosphorylated protein in vivo; diminished MyBP-C phosphorylation is a feature of both end-stage heart failure and hypertrophic cardiomyopathy."}, {"pubmed": 18802026, "text": "PKA phosphorylation of cMyBP-C accelerates crossbridge kinetics and loss of this regulation leads to cardiac dysfunction."}, {"pubmed": 18803133, "text": "Mutations in MYBPC3 should be considered a frequent cause of hypertrophic cardiomyopathy in Poland."}, {"pubmed": 18803133, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18929575, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18929575, "text": "the missense MYBPC3 mutation E334K destabilizes its protein and may contribute to cardiac dysfunction in hypertrophic cardiomyopathy through impairment of the ubiquitin-proteasome system."}, {"pubmed": 18957093, "text": "MYBPC3 mutations can be associated with cardiac events such as progressive heart failure, stroke and sudden death even at younger age"}, {"pubmed": 19035361, "text": "MYBPC3 mutation was found involved in hypertrophic cardiomyopathy."}, {"pubmed": 19149795, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19150014, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19151713, "text": "A deletion of 25 bp in the gene encoding cardiac myosin binding protein C (MYBPC3) that is associated with heritable cardiomyopathies and an increased risk of heart failure in Indian populations."}, {"pubmed": 19151713, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19273718, "text": "Frameshift MYBPC3 mutations cause haploinsufficiency, deranged phosphorylation of contractile proteins, and reduced maximal force-generating capacity of cardiomyocytes"}, {"pubmed": 19293840, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19356534, "text": "Diastolic abnormalities as the first feature of hypertrophic cardiomyopathy in Dutch myosin-binding protein C founder mutations."}, {"pubmed": 19356534, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19403693, "text": "A new ligand of obscurin at the M-band, MyBP-C slow variant-1 and suggest that their interaction contributes to the assembly of M-and A-bands, is identified."}, {"pubmed": 19406073, "text": "description of a family in which some experienced early development of systolic & diastolic dysfunction & others experienced sudden death at young age; identified a novel homozygous mutation (IVS6+5G>A) in MYBPC3 gene that explained the phenotype"}, {"pubmed": 19574547, "text": "The lowered relative level of full length protein in both truncation and missense MYBPC3 mutations argues strongly that haploinsufficiency is sufficient to cause hypertrophic cardiomyopathy."}, {"pubmed": 19666196, "text": "Large deletions and duplications in MYBPC3 do not appear to play a major role in the pathogenesis of hypertrophic cardiomyopathy."}, {"pubmed": 19666645, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19808356, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19808356, "text": "increased myofilament protein levels in patients with MYBPC3-mediated HCM suggest a poison peptide mechanism"}, {"pubmed": 19850579, "text": "atrogin-1 specifically targets truncated M7t-cMyBP-C, but not WT-cMyBP-C, for proteasomal degradation and that MuRF1 indirectly reduces cMyBP-C levels by regulating the transcription of myosin heavy chain."}, {"pubmed": 19853701, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19875404, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20019025, "text": "Observational study of genetic testing. (HuGE Navigator)"}, {"pubmed": 20019025, "text": "Predictive genetic testing in hypertrophic cardiomyopathy families and cardiological evaluation on the presence of HCM and risk factors for sudden cardiac death are justified in hypertrophic cardiomyopathy myosin-binding protein C gene mutation carriers"}, {"pubmed": 20021930, "text": "MYBPC3 mutation is presented in a small portion of Han Chinese patients with hypertrophic cardiomyopathy."}, {"pubmed": 20021930, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20031618, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20128375, "text": "cMYBPC3 might be the disease-causing gene in Chinese patients with hypertrophic cardiomyopathy."}, {"pubmed": 20151718, "text": "Report for the first time that there are four PKA phosphorylation sites in both murine and human M-domains."}, {"pubmed": 20193176, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20193176, "text": "The novel S236G mutation in MYBPC3 gene was a hot-spot mutation in Chinese patients with hypertrophic cardiomyopathy."}, {"pubmed": 20201939, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 20201939, "text": "Results indicate that the MYBPC3 deletion is primarily found among Indian populations and that its distribution is consistent with genome-wide patterns of variation in India."}, {"pubmed": 20215591, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20215591, "text": "The mutations in MYBPC3 cause when a genetic cause can be identified, which has estimated to occur in 42% of hypertrophic cardiomyopathy."}, {"pubmed": 20350521, "text": "The novel mutation S297X in MYBPC3 causes hypertrophic cardiomyopathy in a broad range of ages and heterogeneous clinical manifestations, though the clinical course in patients with this mutation seems to be benign."}, {"pubmed": 20359594, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 20378854, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20378854, "text": "The MYBPC3 Arg502Trp conveys a 340-fold increased risk for HCM by 45 years of age, when more than 50% of carriers have overt disease. HCM prognosis worsens when MYBPC3 Arg502Trp occurs in the setting of another sarcomere protein gene mutation."}, {"pubmed": 20379391, "text": "Species-specific differences between homologous cMyBP-C isoforms confer differential effects that could fine-tune cMyBP-C function in hearts of different species."}, {"pubmed": 20379614, "text": "Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 20414521, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20433692, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20474083, "text": "Observational study of genetic testing. (HuGE Navigator)"}, {"pubmed": 20542340, "text": "The R820W mutation in the MYBPC3 gene causes both hypertrophic cardiomyopathy and left ventricular non-compaction in homozygous human carriers."}, {"pubmed": 20624503, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20689143, "text": "Mutation in MYBPC3 gene is associated with hypertrophic cardiomyopathy."}, {"pubmed": 20740642, "text": "the mean methylation level of CpGs was significantly higher in MYBPC3 than MYBPC2."}, {"pubmed": 20800588, "text": "Observational study of genetic testing. (HuGE Navigator)"}, {"pubmed": 20850451, "text": "A detailed quantitative analysis of MyBP-C phosphorylation in heart tissue in situ, is reported."}, {"pubmed": 20975235, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 21088121, "text": "The MYBPC3 IVS23+1G-->A mutation is associated with middle-age onset disease and poor outcome, with a significant proportion of patients developing systolic impairment and a high sudden death risk profile."}, {"pubmed": 21165360, "text": "the MYBPC3 gene is a common pathogenic gene responsible for HCM in Chinese patients"}, {"pubmed": 21257752, "text": "cMyBP-C is a critical nodal point that has both important structural and signaling roles and whose modifications are known to cause significant human cardiac disease."}, {"pubmed": 21297165, "text": "Data identify a novel interaction between cardiac-specific Ig-like domain C0 and the regulatory light chain of myosin, thus placing the N terminus of the protein in proximity to the motor domain of myosin."}, {"pubmed": 21409595, "text": "These two individuals may be considered to suffer from a combination of both a classical hypertrophic cardiomyopathy (due to the two mutations in MYBPC3) and a glycogen storage cardiomyopathy (due to the mutation in PRKAG2)."}, {"pubmed": 21551322, "text": "identified 5 mutations in cardiac myosin-binding protein C (MYBPC3) and 2 mutations in alpha-tropomyosin (TPM1) in a cohort of unrelated adult probands with isolated left ventricular noncompaction cardiomyopathy"}, {"pubmed": 21821050, "text": "Using electron microscopy and three-dimensional reconstruction, we show that the C0 and the C1 domain can each bind to the same two distinctly different positions on F-actin."}, {"pubmed": 21915287, "text": "The frequency of MYBPC3 DW genotype and D allele was associated with compromised LVEF implying that genetic variants of MYBPC3 encoding mutant structural sarcomere protein could increase susceptibility to left ventricular dysfunction."}, {"pubmed": 21959974, "text": "Four novel mutations in MYBPC3 and one in MYH7 were identified among familial hypertrophic cardiomyopathy patients in India"}, {"pubmed": 21971072, "text": "this study suggests that cMyBP-C is an easily releasable myofilament protein that is dephosphorylated, degraded and released into the circulation post-MI."}, {"pubmed": 21985754, "text": "Gln1233ter mutation of MYBPC3 is a true causative mutation for hypertrophic cardiomyopathy."}, {"pubmed": 22021246, "text": "Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation display reduced myocardial work generation in relation to oxygen consumption, in the absence of hypertrophy and flow abnormalities."}, {"pubmed": 22041450, "text": "New insights into the modular organization and flexibility of the N-terminal half of human cardiac myosin binding protein C were deduced from small-angle X-ray scattering and NMR data. study."}, {"pubmed": 22057632, "text": "MYBPC3 mutations in the hypertrophic cardiomyopathy (Review)"}, {"pubmed": 22267749, "text": "MYMPC3 mutations in families with hypertrophic cardiomyopathy shows marked heterogeneity with incomplete, age-related, and gender specific penetrance."}, {"pubmed": 22296197, "text": "a potential early-stage, cardiac-specific biomarker of ischemia-reperfusion injury"}, {"pubmed": 22314326, "text": "only 1 deletion in MYBPC3 was detected in a cohort of 100 French hypertrophic cardiomyopathy patients which confirms that large, multiple-exon deletions and duplications in MYBPC3 do not account for a noteworthy proportion of HCM cases"}, {"pubmed": 22415774, "text": "Results suggest that mutations in MyBP-C do not alter its mean axial distribution along the thick filament."}, {"pubmed": 22462493, "text": "alpha-tropomyosin-D175N and MYBPC3-Q1061X mutations account for a substantial part of all hypertrophic cardiomyopathy (HCM) cases in the Finnish population. Routine genetic screening of these mutations is warranted in Finnish patients with HCM."}, {"pubmed": 22529996, "text": "SNP rs2290149, located in a genetic cluster of MYBPC3 and MADD gene, was found to be associated with diastolic heart failure."}, {"pubmed": 22801425, "text": "CaM may act as a structural conduit that links cMyBP-C with Ca(2+) signaling pathways to help coordinate phosphorylation events and synchronize the multiple interactions between cMyBP-C, myosin, and actin during the heart muscle contraction."}, {"pubmed": 22907696, "text": "Our observations show that the combination of a missense (p.Glu258Lys) and a splice-site mutation (IVS25-1G>A) profoundly affects the clinical course."}, {"pubmed": 23140321, "text": "Carriers of the IVS20-2A>G mutation in the MYBPC3 gene were diagnosed later in life than carriers with other mutation in the MYBPC3, MHY7, TNNT2 and TNNI3 genes."}, {"pubmed": 23277198, "text": "GSK3beta phosphorylation of Ser133 in the linker domain of cMyBP-C may be a novel mechanism to regulate sarcomere kinetics."}, {"pubmed": 23527136, "text": "Three missense mutations can affect structural properties of the domain C1 and surface charge distributions, which could impact the binding of C1 with other sarcomeric proteins thereby affecting contractile function."}, {"pubmed": 23619294, "text": "cMyBP-C harbors more phosphorylation sites than previously known, with a total of 17 (9 novel) identified phosphorylation sites in vivo. Most sites were primarily located within the N-terminal side of the protein."}, {"pubmed": 23711808, "text": "In Chinese hypertrophic cardiomyopathy, distribution of mutations was 56%. No statistical difference was identified in patients carrying MYBPC3 mutations with regard to clinical characteristics and outcomes."}, {"pubmed": 23782526, "text": "Somatic mutations in MYH7, MYBPC3, TPM1, TNNT2, and TNNI3 do not represent an important etiologic pathway in HCM."}, {"pubmed": 23816408, "text": "Association between insertion mutations in the coding sequence of the MYBPC3 gene and development and pathogenesis of hypertrophic cardiomyopathy."}, {"pubmed": 23840593, "text": "A missense mutation in MYBPC3 causing hypertrophic cardiomyopathy is responsible for a malignant phenotype in homozygotes."}, {"pubmed": 23870641, "text": "G263X mutation of MYBPC3 was found in 7 patients with hypertrophic cardiomyopathy in Asturias, Spain."}, {"pubmed": 23980194, "text": "Results show that the E258K mutation in cardiac myosin binding protein C (cMyBP-C) abolishes interaction between N-terminal cMyBP-C and myosin S2 by directly disrupting the cMyBP-C-S2 interface, independent of cMyBP-C phosphorylation."}, {"pubmed": 24083979, "text": "Hypertrophic cardiomyopathy patients with MYBPC3 mutations have a specific miRNA expression profile."}, {"pubmed": 24186209, "text": "at the cMyBP-C expression levels in hypertrophic cardiomyopathy patients, cross-bridge kinetics are preserved and that the depressed maximal force development is not explained by perturbation of cross-bridge kinetics"}, {"pubmed": 24240729, "text": "In this review, we will address what is known of cMyBP-C's role as a regulator of contraction as well as its role in HCM[review]"}, {"pubmed": 24327208, "text": "cMyBP-C is a key regulator of cardiac contractility. Although mutations in the gene encoding cMyBP-C are a leading cause of hypertrophic cardiomyopathy, little is known about the molecular mechanisms underlying the disease process[review]"}, {"pubmed": 24337456, "text": "cMyBP-C is released in the blood rapidly after cardiac damage and therefore has the potential to positively mark the onset of myocardial infarction."}, {"pubmed": 24337823, "text": "A review of MYBPC3 mutations associated with hypertrophic cardiomyopathy."}, {"pubmed": 24509847, "text": "N-terminal fragment of cardiac myosin-binding protein C (cMyBP-C) impairs myofilament function in human myocardium"}, {"pubmed": 24736382, "text": "Change in the ability of cMyBP-C to bind cardiac actin modified filaments might contribute to the development of disease."}, {"pubmed": 24835277, "text": "Gene-specific severity of cardiac abnormalities may underlie differences in disease onset and suggests that early initiation of metabolic treatment may be beneficial, in particular, in myosin heavy chain (MYH7) mutation carriers"}, {"pubmed": 25058872, "text": "The structural features of the R502W mutation of myosin bindin protein C are described and discussed."}, {"pubmed": 25078086, "text": "A founder MYBPC3 mutation that arose >550 years ago is the predominant cause of hypertrophic cardiomyopathy in Iceland."}, {"pubmed": 25123604, "text": "Although females with MYBPC3 mutations showed later onset of hypertrophic cardiomyopathy, female patients were more symptomatic at diagnosis and had more frequent heart failure events once they had developed hypertrophy."}, {"pubmed": 25281569, "text": "These results demonstrate that MYBPC3 Val762Asp may be associated with unfavorable hypertrophic cardiomyopathy phenotypes"}, {"pubmed": 25335496, "text": "Data indicate that homozygous or compound heterozygous truncating pathogenic myosin binding protein C (MYBPC3) mutations cause severe neonatal cardiomyopathy with features of left ventricular noncompaction and septal defects."}, {"pubmed": 25512492, "text": "These results show that the N-terminal region of MyBP-C stabilizes the ON state of thin filaments and the OFF state of thick filaments and lead to a novel hypothesis for the physiological role of MyBP-C in the regulation of cardiac contractility."}, {"pubmed": 25552695, "text": "This review summarizes evidence that phosphorylation of MyBP-C is a key regulator of cardiac force and contraction."}, {"pubmed": 25740977, "text": "A founder MYBPC3 mutation results in HCM with a high risk of sudden death after the fourth decade of life"}, {"pubmed": 25849606, "text": "Characterization of the novel splicing mutations in cardiomyopathy genes MYBPC3 and TNNT2."}, {"pubmed": 25892673, "text": "Mutations in the MYBPC3 and CASQ2 genes and six combinations between loci in the MYBPC3, MYH7 and CASQ2 genes were responsible for cardiomyopathy risk in a studied cohort."}, {"pubmed": 25971843, "text": "Case Report: double cMyBP-C mutation in a patient with end-stage hypertrophic cardiomyopathy."}, {"pubmed": 26090888, "text": "The detection of MYBPC3 mutation, especially the PTC mutation and double-mutation, may serve as a molecular marker for clinical risk stratification of HCM."}, {"pubmed": 26163040, "text": "Demonstrate that MYBPC3 gene mutations, revealed by next-generation sequencing, were associated with familial and sporadic restrictive cardiomyopathy phenotype in patients."}, {"pubmed": 26178432, "text": "5 out of 102 (4.9%) athletes carried mutations: a heterozygous MYH7 Glu935Lys mutation, a heterozygous MYBPC3 Arg160Trp mutation and another heterozygous MYBPC3 Thr1046Met mutation, all of which had been reported as HCM-associated mutations"}, {"pubmed": 26287277, "text": "the phosphorylation pattern of sMyBP-C is differentially regulated in response to age and disease, suggesting that phosphorylation plays important roles in these processes."}, {"pubmed": 26358504, "text": "Mutations in MYBPC3 are associated with cardiomyopathy. [Review]"}, {"pubmed": 26869393, "text": "Atrial fibrillation occurred in 74 patients with hypertrophic cardiomyopathy (31%), but with no difference among genotype groups (31% in MYBPC3, 37% in MYH7 and 18% in other genotypes, p = 0.15)."}, {"pubmed": 27061026, "text": "In children and young adults, a 2-parameter 12-lead A-ECG score is retrospectively significantly more sensitive and specific than pooled, age-specific conventional ECG criteria for detecting MYBPC3-HCM and in distinguishing such patients from healthy controls, including endurance-trained athletes."}, {"pubmed": 27173948, "text": "we report a patient presenting with a complex phenotype consisting of severe, adult-onset, dilated cardiomyopathy, hearing loss and developmental delay, in which exome sequencing revealed two genetic variants that are inherited from a healthy mother: a variant, in MYBPC3, that is associated with hereditary cardiomyopathy."}, {"pubmed": 27267291, "text": "Mutations in the gene MYBPC3 coding for cardiac myosin-binding protein-C (cMyBP-C), a multi-domain protein, are the most common cause of hypertrophic cardiomyopathy ..This molecular insight suggests that key HCM-causing mutations might significantly modify the native affinity required for the assembly of the domains in cMyBP-C, which is essential for normal cardiac function."}, {"pubmed": 27339502, "text": "Mutation in MYBPC3 was identified as Restrictive Cardiomyopathy - causing mutation."}, {"pubmed": 27348999, "text": "a significant role of MYBPC3 gene mutations in Hypertrophic cardiomyopathy(HCM) disease and can be used for pre-symptomatic diagnosis of at risk family members of affected individuals."}, {"pubmed": 27350668, "text": "The results showed that MYBPC3 25-bp deletion polymorphism was significantly associated with elevated risk of left ventricular dysfunction (LVD), while TTN 18 bp I/D, TNNT2 5 bp I/D and myospryn K2906N polymorphisms did not show any significant association with LVD."}, {"pubmed": 27483260, "text": "MYBPC3 gene mutation is associated with Early-Onset Hypertrophic Cardiomyopathy."}, {"pubmed": 27574918, "text": "MYBPC3 and MYH7 were the most common mutated genes, accounting for 27% of the total Hypertrophic Cardiomyopathy patients and 83% of the putative mutations in the main sarcomeric genes."}, {"pubmed": 27620334, "text": "These findings point to the critical role of MYBPC3 during sarcomere assembly in cardiac myocyte differentiation and suggest developmental influences of MYBPC3 truncating mutations on the mature hypertrophic phenotype."}, {"pubmed": 27737317, "text": "Our study supports that mutations in MYH7 and MYBPC3 should be the first focus of moleculargenetic analysis in HCM, and that mutations in TNNT2 have a low prevalence in Brazilian population. All mutations detected were missense mutations, whereas two mutations in MYH7 had not been described before."}, {"pubmed": 27885498, "text": "MYBPC3 mutation carriers had a high frequency of ventricular arrhythmia and syncope. An absence of family history of sudden death (SD) and past history of syncope are useful prognostic factors in patients with hypertrophic cardiomyopathy. MYH7 and MYBPC3 mutations did not significantly influence prognosis compared to non-carriers. The patients with the MYBPC3 mutation should be closely followed for the possibility of SD."}, {"pubmed": 28029522, "text": "The p.Pro108Alafs*9 mutation is associated with HCM, high penetrance, and disease onset in middle age"}, {"pubmed": 28193612, "text": "Study shows lack of phenotypic differences between MYH7- and MYBPC3-associated hypertrophic cardiomyopathy when assessed by cardiac magnetic resonance imaging."}, {"pubmed": 28202948, "text": "Five of the 19 patients (26.3%) had either a pathogenic variant or a likely pathogenic variant in MYBPC3 (n=1), MYH7 (n=1), RYR2 (n=2), or TNNT2 (n=1). All five variants were missense variants that have been reported previously in patients with channelopathies or cardiomyopathies"}, {"pubmed": 28365402, "text": "Replacement Fibrosis was most abundantly present in the hearts with a MYBPC3 mutation that first presented with a Hypertrophic Cardiomyopathy."}, {"pubmed": 28481356, "text": "The authors demonstrate myosin tail (S2)-dependent functional regulation of actin-activated human beta-cardiac myosin ATPase. In addition, they show that both S2 and MyBP-C bind to S1 and that phosphorylation of either S1 or MyBP-C weakens these interactions."}, {"pubmed": 28614222, "text": "Study showed that CACNB2 is a possible candidate hypertrophy-modifying gene contributing to disease variability of MYBPC3-associated familial hypertrophic cardiomyopathy"}, {"pubmed": 28658286, "text": "mutations associated with a reduced super-relaxed state in hypertrophic cardiomyopathy"}, {"pubmed": 28679633, "text": "pathogenic gene mutations in LMNA and MYBPC3 alter RNA splicing and may have a role in heart disease"}, {"pubmed": 28699631, "text": "Double heterozygotes for mutations in DSP and MYBPC3 showed a variable clinical presentation of arrhythmogenic cardiomyopathy and hypertrophic cardiomyopathy."}, {"pubmed": 28867610, "text": "Our data demonstrate a critical role of the MLP/MyBP-C complex during early myoblast differentiation. Its absence in muscles with mutations or aberrant expression of MLP or MyBP-C could be directly implicated in the development of cardiac and skeletal myopathies."}, {"pubmed": 29053178, "text": "A total of 98 of 155 gene-tested patients carried a non-benign variant. The primary affected gene was MYH7 in 35% (MYH7+) and MYBPC3 in 49% (MYBPC3+). MYH7+ patients had earlier disease onset and higher risk of major adverse cardiac events (MACE)"}, {"pubmed": 29121657, "text": "Data provide evidence that MYBPC3 mutations constitute the preeminent cause of hypertrophic cardiomyopathy (HCM) and that they are phenotypically indistinguishable from HCM caused by MYH7 mutations."}, {"pubmed": 29196542, "text": "Serum cMyC concentration is associated with myocardial hypertrophy, fibrosis and an increased risk of mortality in aortic stenosis."}, {"pubmed": 29386531, "text": "Of the 52 hypertrophic cardiomyopathy patients 11 (21.2%) had MYBPC3 variants."}, {"pubmed": 29451820, "text": "A missense mutation in cardiac myosin-binding protein C linked to hypertrophic cardiomyopathy decreases stability of the fibronectin type III domain and results in substantially reduced mutant protein expression dissonant to transcript abundance."}, {"pubmed": 29524613, "text": "Compound heterozygous mutations in MYBPC3 were identified as a cause of severe familial hypertrophic cardiomyopathy."}, {"pubmed": 29631964, "text": "The authors describe a pathogenic variant in MYBPC3 that shares with most truncating pathogenic variants in this gene 3 characteristics of : a late onset; a relatively benign clinical course in the young; and a high age-dependent penetrance."}, {"pubmed": 29641836, "text": "MYBPC3Delta25bp/D389V is associated with hyperdynamic features, which are an early finding in hypertrophic cardiomyopathy, in South Asian descendants in the United States."}, {"pubmed": 29654880, "text": "A discrete Bayes network interprets fulfilled and predicted 4ddps with conditional probabilities for phenotype and pathogenicity given mutation location and residue substitution thus relating the neural network implicit model to explicit features of the motor and mybpc3 sequence and structural domains."}, {"pubmed": 29663722, "text": "Conflicting interpretations of pathogenicity have been reported for the Pro873His MYBPC3 variant described here. Our patient, presenting with two copies of the variant and devoid of a normal allele, progressed to end-stage heart failure, which supports the notion of a deleterious effect of this variant in the homozygous form."}, {"pubmed": 29716714, "text": "MYBPC3 does not seem to play a role in anthracycline induced cardiotoxicity."}, {"pubmed": 29875314, "text": "Study of intraventricular septum samples from hypertrophic cardiomyopathy patients and a panel of human MYBPC3 mutations expressed in neonatal rat ventricular cardiomyocytes revealed suggest that wild type and mutant MYBPC3 proteins are clients for HSC70, and that the HSC70 chaperone system plays a major role in regulating MYBPC3 protein turnover."}, {"pubmed": 30170119, "text": "This is the first study to demonstrate intercellular variation of myofilament cMyBP-C protein expression within the myocardium from HCM patients with heterozygous MYBPC3 mutations."}, {"pubmed": 30282064, "text": "Report age-at-death variations among MYBPC3 protein-truncating variant carriers in adult males."}, {"pubmed": 30446606, "text": "A zebrafish model proved to be a useful tool to characterize the pathogenicity of human c-MYBPC3 missense mutations identified in patients with cardiac disease."}, {"pubmed": 30550750, "text": "hypertrophic cardiomyopathy-causing MYBPC3 truncation mutations result in a loss of MyBP-C content that enhances maximal myofilament sliding velocities, only where MyBP-C is localized within the C-zone."}, {"pubmed": 30586709, "text": "isogenic induced pluripotent stem cell-derived cardiomyocytes carrying MYBPC3 premature termination codon mutations displayed aberrant calcium signaling and molecular dysregulations in the absence of significant haploinsufficiency of MYBPC3 protein"}, {"pubmed": 30645170, "text": "MYBPC3 Splice-Site Variants are associated with Hypertrophic Cardiomyopathy."}, {"pubmed": 30674652, "text": "These data define dosage-dependent effects of cMyBPC on myosin that occur across the cardiac cycle as the pathophysiologic mechanisms by which MYBPC3 truncations cause Hypertrophic cardiomyopathy."}, {"pubmed": 30862451, "text": "these findings demonstrate the physiological significance of calpain-targeted cMyBP-C proteolysis."}, {"pubmed": 30871747, "text": "31 rare variants in eight genes (mainly in MYBPC3, TNNT2 and LMNA) were identified, in 28 patients (26%). Only four variants had been previously described in association with DCM, 11 with hypertrophic cardiomyopathy, and nine variants were novel"}, {"pubmed": 30877248, "text": "the longer N-terminal fragment (C0C3) must possess the requisite domains needed to bind specifically to the thin filament in order for the cMyBP-C N terminus to modulate cardiac contractility."}, {"pubmed": 30924982, "text": "Results identified a loss-of-function (LoF) variant in a compound heterozygous state with a missense variant in MYBPC3 leading to severe cardiomyopathy with left ventricular noncompaction. haploinsufficiency in MYBPC3 results in a severe early-onset ventricular noncompaction phenotype requiring heart transplantation when combined with a de novo missense variant on the second allele."}, {"pubmed": 30947911, "text": "Eleven MYBPC3 mutations in 8 families with 9 patients with noncompaction cardiomyopathy were observed."}, {"pubmed": 30976029, "text": "CMR derived left ventricular septal convexity in carriers of the hypertrophic cardiomyopathy-causing MYBPC3-Q1061X mutation."}, {"pubmed": 31142654, "text": "The phosphorylation-dependent interaction between cMyBP-C and myosin is a determinant of the fraction of myosin available for contraction."}, {"pubmed": 31568709, "text": "ALU transposition induces familial hypertrophic cardiomyopathy."}, {"pubmed": 31730716, "text": "Whole MYBPC3 NGS sequencing as a molecular strategy to improve the efficiency of molecular diagnosis of patients with hypertrophic cardiomyopathy."}, {"pubmed": 31747981, "text": "A novel MYBPC3 c.2737+1 (IVS26) G>T mutation responsible for high-risk hypertrophic cardiomyopathy."}, {"pubmed": 31877118, "text": "Effects of MYBPC3 loss-of-function mutations preceding hypertrophic cardiomyopathy."}, {"pubmed": 31919335, "text": "Identification of a variant hotspot in MYBPC3 and of a novel CSRP3 autosomal recessive alteration in a cohort of Polish patients with hypertrophic cardiomyopathy."}, {"pubmed": 31943169, "text": "Functional characterization of human myosin-binding protein C3 variants associated with hypertrophic cardiomyopathy reveals exon-specific cardiac phenotypes in zebrafish model."}, {"pubmed": 31996869, "text": "Genes frequently associated with sudden death in primary hypertrophic cardiomyopathy.\", trans \"Genes frecuentemente asociados con muerte subita en miocardiopatia hipertrofica primaria."}, {"pubmed": 32030882, "text": "Genetic screening for hypertrophic cardiomyopathy in large, asymptomatic military cohorts."}, {"pubmed": 32034629, "text": "Protein Thermodynamic Destabilization in the Assessment of Pathogenicity of a Variant of Uncertain Significance in Cardiac Myosin Binding Protein C."}, {"pubmed": 32163302, "text": "Reevaluation of the South Asian MYBPC3(Delta25bp) Intronic Deletion in Hypertrophic Cardiomyopathy."}, {"pubmed": 32217077, "text": "Mutation-specific pathology and treatment of hypertrophic cardiomyopathy in patients, mouse models and human engineered heart tissue."}, {"pubmed": 32341788, "text": "Men are more likely to have LVH at a younger age, and disease manifestations were more prominent in probands than in relatives identified via family screening."}, {"pubmed": 32396390, "text": "Cryptic Splice-Altering Variants in MYBPC3 Are a Prevalent Cause of Hypertrophic Cardiomyopathy."}, {"pubmed": 32841044, "text": "Spatial and Functional Distribution of MYBPC3 Pathogenic Variants and Clinical Outcomes in Patients With Hypertrophic Cardiomyopathy."}, {"pubmed": 32976931, "text": "Post-translational regulation of cardiac myosin binding protein-C: A graphical review."}, {"pubmed": 33588347, "text": "Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy."}, {"pubmed": 33757590, "text": "Multi-omics integration identifies key upstream regulators of pathomechanisms in hypertrophic cardiomyopathy due to truncating MYBPC3 mutations."}, {"pubmed": 33830315, "text": "Gender- and age-related differences in distinct phenotypes of hypertrophic cardiomyopathy-associated mutation MYBPC3-E334K."}, {"pubmed": 34051236, "text": "Mutations in myosin S2 alter cardiac myosin-binding protein-C interaction in hypertrophic cardiomyopathy in a phosphorylation-dependent manner."}, {"pubmed": 34052227, "text": "Cardiac myosin-binding protein C interaction with actin is inhibited by compounds identified in a high-throughput fluorescence lifetime screen."}, {"pubmed": 34097875, "text": "Protein haploinsufficiency drivers identify MYBPC3 variants that cause hypertrophic cardiomyopathy."}, {"pubmed": 34180388, "text": "Novel pathogenic variant of MYBPC3 responsible for hypertrophic cardiomyopathy."}, {"pubmed": 34310159, "text": "Myocardial Perfusion Defects in Hypertrophic Cardiomyopathy Mutation Carriers."}, {"pubmed": 34329643, "text": "Interaction of the C2 Ig-like Domain of Cardiac Myosin Binding Protein-C with F-actin."}, {"pubmed": 34400558, "text": "Cardiac myosin binding protein-C variants in paediatric-onset hypertrophic cardiomyopathy: natural history and clinical outcomes."}, {"pubmed": 34588271, "text": "Founder mutation in myosin-binding protein C with an early onset and a high penetrance in males."}, {"pubmed": 34600606, "text": "Hypertrophic cardiomyopathy: a practical approach to guideline directed management."}, {"pubmed": 34680864, "text": "Myocardial Deformation Analysis in MYBPC3 and MYH7 Related Sarcomeric Hypertrophic Cardiomyopathy-The Graz Hypertrophic Cardiomyopathy Registry."}, {"pubmed": 34769381, "text": "Assessment of the Contribution of a Thermodynamic and Mechanical Destabilization of Myosin-Binding Protein C Domain C2 to the Pathomechanism of Hypertrophic Cardiomyopathy-Causing Double Mutation MYBPC3(Delta25bp/D389V)."}, {"pubmed": 34965010, "text": "Inhibition of HSC70 alleviates hypertrophic cardiomyopathy pathology in human induced pluripotent stem cell-derived cardiomyocytes with a MYBPC3 mutation."}, {"pubmed": 35508642, "text": "Identification of an elusive spliceogenic MYBPC3 variant in an otherwise genotype-negative hypertrophic cardiomyopathy pedigree."}, {"pubmed": 35717150, "text": "MicroRNA expression profiles in familial hypertrophic cardiomyopathy with myosin-binding protein C3 (MYBPC3) gene mutations."}, {"pubmed": 36162733, "text": "The <<Amish>> NM_000256.3:c.3330+2T>G splice variant in MYBPC3 associated with hypertrophic cardiomyopathy is an ancient Swiss mutation."}, {"pubmed": 36744470, "text": "Slower Calcium Handling Balances Faster Cross-Bridge Cycling in Human MYBPC3 HCM."}, {"pubmed": 36893011, "text": "cMyBP-C ablation in human engineered cardiac tissue causes progressive Ca2+-handling abnormalities."}, {"pubmed": 36946992, "text": "Is haploinsufficiency a sufficient mechanism for MYBPC3 truncating mutations?"}, {"pubmed": 37002766, "text": "Identification of Variants and Mutational Analyses of Cardiac Myosin-binding Protein C (MYBPC3) Gene of Adult Bangladeshi Patients with Hypertrophic Cardiomyopathy."}, {"pubmed": 37061858, "text": "[No Effect of the p.Arg230His Variant Of The VCL Protein on the Course of the Hypertrophic Cardiomyopathy In Russian Family Carrying The p.Gln1233Ter Pathogenic Variant In The MYBPC3 Gene]."}, {"pubmed": 37107598, "text": "Description of a Cohort with a New Truncating MYBPC3 Variant for Hypertrophic Cardiomyopathy in Northern Spain."}, {"pubmed": 37409452, "text": "Long-Term Prevalence of Systolic Dysfunction in MYBPC3 Versus MYH7-Related Hypertrophic Cardiomyopathy."}, {"pubmed": 37445689, "text": "An Update on MYBPC3 Gene Mutation in Hypertrophic Cardiomyopathy."}, {"pubmed": 37797718, "text": "Nonsense mediated decay factor UPF3B is associated with cMyBP-C haploinsufficiency in hypertrophic cardiomyopathy patients."}, {"pubmed": 37963751, "text": "[Clinical phenotype and genetic analysis of patients with left ventricular noncompaction caused by the biallelic mutation of MYBPC3 and MYH7]."}, {"pubmed": 38042491, "text": "Missense mutations in the central domains of cardiac myosin binding protein-C and their potential contribution to hypertrophic cardiomyopathy."}, {"pubmed": 38258577, "text": "A Promoter Deletion Confirms That MYBPC3 Haploinsufficiency Is Sufficient to Cause Hypertrophic Cardiomyopathy in Humans."}, {"pubmed": 38387507, "text": "Missense variants in phospholamban and cardiac myosin binding protein identified in patients with a family history and clinical diagnosis of dilated cardiomyopathy."}, {"pubmed": 38456273, "text": "Genetic Testing Yield and Clinical Characteristics of Hypertrophic Cardiomyopathy in Understudied Ethnic Groups: Insights From a New Zealand National Registry."}, {"pubmed": 38877002, "text": "Cardiac myosin binding protein-C phosphorylation as a function of multiple protein kinase and phosphatase activities."}], "genomic_pos": {"chr": "11", "end": 47352702, "ensemblgene": "ENSG00000134571", "start": 47331406, "strand": -1}, "genomic_pos_hg19": {"chr": "11", "end": 47374253, "start": 47352957, "strand": -1}, "go": {"BP": [{"evidence": "IMP", "gocategory": "BP", "id": "GO:0003007", "pubmed": 7493025, "qualifier": "involved_in", "term": "heart morphogenesis"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0006942", "qualifier": "involved_in", "term": "regulation of striated muscle contraction"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0007155", "qualifier": "involved_in", "term": "cell adhesion"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0032781", "qualifier": "involved_in", "term": "positive regulation of ATP-dependent activity"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0032971", "qualifier": "involved_in", "term": "regulation of muscle filament sliding"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0045214", "qualifier": "involved_in", "term": "sarcomere organization"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0055010", "qualifier": "involved_in", "term": "ventricular cardiac muscle tissue morphogenesis"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0055010", "pubmed": [11815426, 16754800], "qualifier": "involved_in", "term": "ventricular cardiac muscle tissue morphogenesis"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0060048", "qualifier": "involved_in", "term": "cardiac muscle contraction"}], "CC": [{"evidence": "TAS", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005863", "pubmed": 10024460, "qualifier": "located_in", "term": "striated muscle myosin thick filament"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0005863", "qualifier": "located_in", "term": "striated muscle myosin thick filament"}, {"evidence": "NAS", "gocategory": "CC", "id": "GO:0014705", "pubmed": 15166115, "qualifier": "located_in", "term": "C zone"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0030017", "pubmed": 10024460, "qualifier": "located_in", "term": "sarcomere"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0031430", "qualifier": "is_active_in", "term": "M band"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0031672", "pubmed": [10024460, 19850579], "qualifier": "located_in", "term": "A band"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0097512", "pubmed": 25771144, "qualifier": "located_in", "term": "cardiac myofibril"}], "MF": [{"category": "MF", "evidence": "ISS", "id": "GO:0001671", "qualifier": "enables", "term": "ATPase activator activity"}, {"category": "MF", "evidence": "IEA", "id": "GO:0003779", "qualifier": "enables", "term": "actin binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": 21569246, "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IMP", "id": "GO:0008307", "pubmed": 7493025, "qualifier": "enables", "term": "structural constituent of muscle"}, {"category": "MF", "evidence": "IDA", "id": "GO:0017022", "pubmed": 10024460, "qualifier": "enables", "term": "myosin binding"}, {"category": "MF", "evidence": "NAS", "id": "GO:0031432", "pubmed": 7493025, "qualifier": "enables", "term": "titin binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0032036", "qualifier": "enables", "term": "myosin heavy chain binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0032036", "pubmed": 17192269, "qualifier": "enables", "term": "myosin heavy chain binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0042802", "pubmed": 18201573, "qualifier": "enables", "term": "identical protein binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0046872", "qualifier": "enables", "term": "metal ion binding"}]}, "homologene": {"genes": [[7955, 556489], [8364, 100127177], [9031, 396013], [9544, 712093], [9598, 451168], [9606, 4607], [9615, 483624], [9913, 767614], [10090, 17868], [10116, 295929]], "id": 215}, "interpro": [{"desc": "Immunoglobulin subtype 2", "id": "IPR003598", "short_desc": "Ig_sub2"}, {"desc": "Immunoglobulin subtype", "id": "IPR003599", "short_desc": "Ig_sub"}, {"desc": "Fibronectin type III", "id": "IPR003961", "short_desc": "FN3_dom"}, {"desc": "Immunoglobulin-like domain", "id": "IPR007110", "short_desc": "Ig-like_dom"}, {"desc": "Immunoglobulin I-set", "id": "IPR013098", "short_desc": "Ig_I-set"}, {"desc": "Immunoglobulin-like fold", "id": "IPR013783", "short_desc": "Ig-like_fold"}, {"desc": "Fibronectin type III superfamily", "id": "IPR036116", "short_desc": "FN3_sf"}, {"desc": "Immunoglobulin-like domain superfamily", "id": "IPR036179", "short_desc": "Ig-like_dom_sf"}, {"desc": "MyBP-C, tri-helix bundle domain", "id": "IPR040849", "short_desc": "MyBP-C_THB"}], "ipi": ["IPI00292412", "IPI00798035"], "map_location": "11p11.2", "name": "myosin binding protein C3", "other_names": ["myosin binding protein C, cardiac", "myosin-binding protein C, cardiac-type"], "pantherdb": {"HGNC": "7551", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "102844", "ortholog_type": "LDO", "panther_family": "PTHR13817", "taxid": 10090, "uniprot_kb": "O70468"}, {"RGD": "1305950", "ortholog_type": "LDO", "panther_family": "PTHR13817", "taxid": 10116, "uniprot_kb": "P56741"}, {"Gene": "MYBPC3", "ortholog_type": "O", "panther_family": "PTHR13817", "taxid": 9031, "uniprot_kb": "Q90688"}, {"Ensembl": "ENSGALG00000008148", "ortholog_type": "LDO", "panther_family": "PTHR13817", "taxid": 9031, "uniprot_kb": "A0A1D5PKM9"}, {"ZFIN": "ZDB-GENE-070112-2362", "ortholog_type": "LDO", "panther_family": "PTHR13817", "taxid": 7955, "uniprot_kb": "A0A1L1QZU5"}, {"WormBase": "WBGene00006759", "ortholog_type": "O", "panther_family": "PTHR13817", "taxid": 6239, "uniprot_kb": "Q23551"}, {"FlyBase": "FBgn0005666", "ortholog_type": "O", "panther_family": "PTHR13817", "taxid": 7227, "uniprot_kb": "D1YSG0"}], "uniprot_kb": "Q14896"}, "pathway": {"kegg": [{"id": "hsa05410", "name": "Hypertrophic cardiomyopathy - Homo sapiens (human)"}, {"id": "hsa05414", "name": "Dilated cardiomyopathy - Homo sapiens (human)"}], "reactome": [{"id": "R-HSA-390522", "name": "Striated Muscle Contraction"}, {"id": "R-HSA-397014", "name": "Muscle contraction"}], "wikipathways": {"id": "WP383", "name": "Striated Muscle Contraction Pathway"}}, "pdb": ["1GXE", "1PD6", "2AVG", "2K1M", "2MQ0", "2MQ3", "2V6H", "3CX2", "5K6P", "6CXI", "6CXJ", "6G2T", "7LRG", "7TIJ", "7TIT", "7TJ7", "8G4L"], "pfam": ["PF00041", "PF07679", "PF18362"], "pharmgkb": "PA31351", "pharos": {"target_id": 2670, "tdl": "Tbio"}, "pir": "S55050", "prosite": ["PS50835", "PS50853"], "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF226954", "relationship": "is"}, {"id": "GNF253023", "relationship": "is"}, {"id": "GNF253024", "relationship": "is"}, {"id": "GNF253025", "relationship": "is"}, {"id": "GNF253026", "relationship": "is"}], "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF086292", "relationship": "is"}, {"id": "GNF086293", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF053846", "relationship": "is"}, {"id": "GNF073870", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF069899", "relationship": "is"}, {"id": "GNF069900", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF105597", "relationship": "is"}, {"id": "GNF145243", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000011.10", "NC_060935.1", "NG_007667.1"], "protein": "NP_000247.2", "rna": "NM_000256.3", "translation": {"protein": "NP_000247.2", "rna": "NM_000256.3"}}, "reporter": {"HG-U133_Plus_2": "208040_s_at", "HG-U95Av2": "35038_at", "HTA-2_0": "TC11001735.hg.1", "HuEx-1_0": ["3372129", "4037638"], "HuGene-1_1": ["7947828", "8165669"], "HuGene-2_1": ["16737976", "17100665"]}, "summary": "MYBPC3 encodes the cardiac isoform of myosin-binding protein C. Myosin-binding protein C is a myosin-associated protein found in the cross-bridge-bearing zone (C region) of A bands in striated muscle. MYBPC3 is expressed exclusively in heart muscle and is a key regulator of cardiac contraction. Mutations in this gene are a frequent cause of familial hypertrophic cardiomyopathy. [provided by RefSeq, May 2022].", "symbol": "MYBPC3", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1417523"}, "unigene": "Hs.524906", "uniprot": {"Swiss-Prot": "Q14896", "TrEMBL": ["F5GZR4", "A5YM48", "A8MXZ9"]}, "wikipedia": {"url_stub": "Myosin binding protein C, cardiac"}}